The management of newly diagnosed large B-cell lymphoma: A British Society for Haematology Guideline

The management of newly diagnosed large B-cell lymphoma: A British Society for Haematology Guideline

This BSH guideline summarises the recommended initial investigation and first-line management of large B-cell lymphoma (LBCL). Primary extra-nodal LBCL is discussed in this guideline, with the exception of lymphoma involving the central nervous system, covered by separate BSH guideline publications.^{1, 2} Post-transplant lymphoproliferative disorders are also covered by a separate guideline.³ The investigation and management of primary mediastinal large B-cell lymphoma, mediastinal grey-zone lymphoma, primary cutaneous LBCL, primary effusion lymphoma, plasmablastic lymphoma and Burkitt lymphoma are also beyond the scope of this guideline. The management of relapsed LBCL is covered in a separate guideline.


Read full Guideline